EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

( S )‐Pyrrolo[1,2‐ a ]pyrazine‐3‐carboxamide Analogs as Dual Akt/JNK Modulators With Antiproliferative Effects in MDA‐MB‐468 Cells

Narges Hosseininasab, Sou Hyun Kim, Ye-Mi Kwon, Jungjin Park, Chanhyun Jung, Kwanghee Lee, Beom-Jun Wi, Su-Jin Yoo, Soonsil Hyun iD, Young-Suk Jung, Jae-Hwan Kwak iD

ChemMedChem · 2026

DOI: 10.1002/cmdc.70463 ↗

At a glance

Journal article in ChemMedChem, 2026. Written by Narges Hosseininasab and 10 co-authors. Institution: College of Pharmacy, Chungbuk National University, Cheongju, Chungbuk, Republic of Korea. Major MEDLINE topics: Proto-Oncogene Proteins c-akt, Antineoplastic Agents, Pyrazines, Protein Kinase Inhibitors. 35 references. The full text is freely available (open access, CC BY 4.0). Funded by: Chungbuk National University, National Research Foundation of Korea, Korea government (MSIT).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Triple‐negative breast cancer (TNBC) remains a major clinical challenge due to the absence of effective targeted therapies. In this study, thirty analogs of ( S )‐1‐oxo‐1,2,3,4‐tetrahydropyrrolo[1,2‐ a ]pyrazine‐3‐carboxamide ( A1 – F5 ) were designed, synthesized, and evaluated for their cytotoxic activity against hormone receptor‐positive breast cancer (MCF‐7) and EGFR‐overexpressing TNBC (MDA‐MB‐468) cell lines. Notably, compounds B1 and B3 exhibited potent growth inhibition toward MDA‐MB‐468 cells, with GI 50 values of 2.8 and 4.7 µM, respectively, surpassing the efficacy of the reference compound ( Ref 2 , GI 50 : 7.6 µM) and gefitinib (GI 50 : 16.5 µM). Flow cytometric analysis demonstrated significant apoptosis induction by compounds B1 and B3 , with rates of 42.8% and 42.2%, respectively. Mechanistic investigations revealed that compounds B1 and B3 selectively inhibited Akt phosphorylation and enhanced JNK phosphorylation, suggesting a dual modulation of survival and apoptotic pathways. These findings support the development of N2 ‐benzyl‐( S )‐1‐oxo‐1,2,3,4‐tetrahydropyrrolo[1,2‐ a ]pyrazine‐3‐carboxamide analogs, particularly compound B1 , as selective therapeutic candidates for triple‐negative breast cancer.

Subjects

MeSH terms (MEDLINE)

Proto-Oncogene Proteins c-aktAntineoplastic AgentsPyrazinesProtein Kinase InhibitorsPyrrolesHumansCell ProliferationStructure-Activity RelationshipDrug Screening Assays, AntitumorApoptosisCell Line, TumorMolecular StructureDose-Response Relationship, Drug

Author keywords

JNK phosphorylationMDA‐MB‐468 cellcytotoxic activitypyrrolopyrazine scaffoldtriple‐negative breast cancer

Substances

Proto-Oncogene Proteins c-aktAntineoplastic AgentsPyrazinesProtein Kinase InhibitorsPyrroles

Authors and institutions

  • College of Pharmacy, Chungbuk National University, Cheongju, Chungbuk, Republic of Korea.
  • College of Pharmacy, Research Institute for Drug Development, Pusan National University, Busan, Republic of Korea.
  • Development Center (NDDC), Daegu-Gyeongbuk Medical Innovation Foundation (KMEDIhub), Daegu, Republic of Korea.

ORCID profiles: Soonsil Hyun, Jae-Hwan Kwak

Funding

  • Chungbuk National University
  • National Research Foundation of Korea
  • Korea government (MSIT)

Cite

APA

Hosseininasab, N., Kim, S. H., Kwon, Y. M., Park, J., Jung, C., Lee, K., Wi, B. J., Yoo, S. J., Hyun, S., Jung, Y. S., & Kwak, J. H. (2026). ( S )‐Pyrrolo[1,2‐ a ]pyrazine‐3‐carboxamide Analogs as Dual Akt/JNK Modulators With Antiproliferative Effects in MDA‐MB‐468 Cells. ChemMedChem. https://doi.org/10.1002/cmdc.70463

Vancouver

Hosseininasab N, Kim SH, Kwon YM, Park J, Jung C, Lee K, et al. ( S )‐Pyrrolo[1,2‐ a ]pyrazine‐3‐carboxamide Analogs as Dual Akt/JNK Modulators With Antiproliferative Effects in MDA‐MB‐468 Cells. ChemMedChem. 2026. doi:10.1002/cmdc.70463

BibTeX
@article{Hosseininasab2026,
  author = {Hosseininasab, Narges and Kim, Sou Hyun and Kwon, Ye-Mi and Park, Jungjin and Jung, Chanhyun and Lee, Kwanghee and Wi, Beom-Jun and Yoo, Su-Jin and Hyun, Soonsil and Jung, Young-Suk and Kwak, Jae-Hwan},
  title = {( S )‐Pyrrolo[1,2‐ a ]pyrazine‐3‐carboxamide Analogs as Dual Akt/JNK Modulators With Antiproliferative Effects in MDA‐MB‐468 Cells},
  journal = {ChemMedChem},
  year = {2026},
  doi = {10.1002/cmdc.70463}
}
Start for free →